Bio Storage and Transportation System handles dried specimens.
Press Release Summary:
Intended to be used for biological specimens as alternative to frozen plasma or dried blood spots, ViveST™ Matrix allows specimen to be handled without refrigeration and expands sample collection to remote areas. Dried sample can be reconstituted into robust specimen that can be used in downstream applications including RNA/DNA targets, cell recovery, and protein analysis allowing for use with such tests as viral load quantification, genotyping, and sequencing.
Original Press Release:
ViveBio Introduces Next-Generation ViveST(TM) Matrix to Expand Healthcare Access and Lower Specimen Transportation Costs
ALPHARETTA, Ga. – ViveBio, LLC announced today the introduction of its next-generation ViveST(TM) proprietary matrix for the storage and transportation of biological specimens, expanding sample collection to remote areas and lowering specimen transportation costs. With the new matrix, the dried sample can be easily reconstituted into a robust specimen that can be used in multiple downstream applications including RNA/DNA targets, cell recovery, and protein analysis allowing for use with such tests as viral load quantification, genotyping and sequencing.
ViveST(TM) is a high volume, dried specimen storage and transportation system that allows the specimen to be handled without refrigeration. The device is intended to be used for biological specimens as an alternative to frozen plasma or dried blood spots. The benefits of ViveST(TM) include:
--Â Ambient transport and storage of specimens eliminating the time and cost of preparing and shipping frozen samples
--Â Easy to use workflow with rapid turnaround time
--Â High sample volume of 1.0-1.5 mL that is often required for testing
The key feature of the ViveST(TM) is a proprietary absorbent matrix on which a biological specimen can be loaded by simple pipetting and allowed to dry. During the drying process, water in the biological sample is evaporated but biological analytes including proteins, virions and nucleic acids remain in the matrix.
ViveST(TM) is CE marked and has received ANVISA medical device registration in Brazil. Performance data using this next-generation matrix was recently presented at the International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies held June 4-8, 2013 in Toronto, Canada and the 29th Clinical Virology Symposium held April 28-May 1, 2013 in Daytona Beach, Florida. For more information regarding ViveST(TM) and recent scientific publications and posters, please visit the ViveBio website at www.vivebio.com or contact Richard Carroll, PhD, at carroll@vivebio.com or Brad Nelson at nelson@vivebio.com or 877-814-7004.
About ViveBio, LLC
ViveBio, LLC is a privately held biotechnology company focused on providing cost-effective solutions for biological specimen transportation and storage. ViveBio's mission is to expand access to healthcare and extend life through these cost effective solutions and other breakthrough technologies. The company's initial focus has been to address the need for transporting plasma for HIV, Hepatitis C and Hepatitis B viral load and genotype tests. ViveBio's manufacturing and corporate office is located in Alpharetta, Georgia.
Web Site: http://www.vivebio.com
